Common Contracts
3 similar Employment Agreement contracts by Revolution Medicines, Inc., Eargo, Inc.
EARGO, INC. EMPLOYMENT AGREEMENTEmployment Agreement • March 23rd, 2023 • Eargo, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • California
This Employment Agreement (the “Agreement”), entered into effective as of January 16, 2022 (the “Effective Date”), is between Eargo, Inc., a Delaware corporation (the “Company”) and Mark Thorpe (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of September 10, 2019 (“Offer Letter”).
REVOLUTION MEDICINES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • May 9th, 2022 • Revolution Medicines, Inc. • Biological products, (no disgnostic substances) • California
This Employment Agreement (the “Agreement”), entered into effective as of April 29, 2022 (the “Effective Date”), is between Revolution Medicines, Inc., a Delaware corporation (the “Company”) and Jack Anders (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of June 29, 2018 and the certain Employment Agreement between Executive and the Company dated as of December 18, 2019 (together, the “Prior Agreements”).
REVOLUTION MEDICINES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • May 9th, 2022 • Revolution Medicines, Inc. • Biological products, (no disgnostic substances) • California
This Employment Agreement (the “Agreement”), entered into effective as of April 28, 2022 (the “Effective Date”), is between Revolution Medicines, Inc., a Delaware corporation (the “Company”) and Xiaolin Wang, Sc.D. (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of March 2, 2018 and the certain Employment Agreement between Executive and the Company dated as of December 18, 2019 (together, the “Prior Agreements”).
